Multiple Sclerosis and Related Disorders,
Год журнала:
2023,
Номер
77, С. 104869 - 104869
Опубликована: Июль 2, 2023
Patient
stratification
and
individualized
treatment
decisions
based
on
multiple
sclerosis
(MS)
clinical
phenotypes
are
arbitrary.
Subtype
Staging
Inference
(SuStaIn),
a
published
machine
learning
algorithm,
was
developed
to
identify
data-driven
disease
subtypes
with
distinct
temporal
progression
patterns
using
brain
magnetic
resonance
imaging;
its
utility
has
not
been
assessed.
The
objective
of
this
study
explore
the
prognostic
capability
SuStaIn
subtyping
whether
it
is
useful
personalized
predictor
effects
natalizumab
dimethyl
fumarate.Subtypes
were
available
from
trained
model
for
3
phase
trials
in
relapsing-remitting
secondary
progressive
MS.
Regression
models
used
determine
baseline
could
predict
on-study
radiological
activity
progression.
Differences
responses
relative
placebo
between
determined
interaction
terms
subtype.Natalizumab
fumarate
reduced
inflammatory
all
(all
p
<
0.001).
MS
alone
did
discriminate
responder
heterogeneity
new
lesion
formation
(p
>
0.05
across
subtypes).SuStaIn
correlated
severity
functional
impairment
at
but
predictive
disability
response
heterogeneity.
Current Neurology and Neuroscience Reports,
Год журнала:
2024,
Номер
24(8), С. 233 - 243
Опубликована: Июнь 28, 2024
Abstract
In
this
paper,
we
analyse
the
different
advances
in
artificial
intelligence
(AI)
approaches
multiple
sclerosis
(MS).
AI
applications
MS
range
across
investigation
of
disease
pathogenesis,
diagnosis,
treatment,
and
prognosis.
A
subset
AI,
Machine
learning
(ML)
models
various
data
sources,
including
magnetic
resonance
imaging
(MRI),
genetic,
clinical
data,
to
distinguish
from
other
conditions,
predict
progression,
personalize
treatment
strategies.
Additionally,
have
been
extensively
applied
lesion
segmentation,
identification
biomarkers,
prediction
outcomes,
monitoring,
management.
Despite
big
promises
solutions,
model
interpretability
transparency
remain
critical
for
gaining
clinician
patient
trust
these
methods.
The
future
holds
potential
open
initiatives
that
could
feed
ML
increasing
generalizability,
implementation
federated
solutions
training
addressing
sharing
issues,
generative
address
challenges
interpretability,
transparency.
conclusion,
presents
an
opportunity
advance
our
understanding
management
MS.
aid
clinicians
diagnosis
prognosis
improving
outcomes
quality
life,
however
ensuring
AI-generated
results
is
going
be
key
facilitating
integration
into
practice.
Royal Society Open Science,
Год журнала:
2025,
Номер
12(1)
Опубликована: Янв. 1, 2025
Multiple
sclerosis
(MS)
is
an
autoimmune
disease
of
the
brain
and
spinal
cord
with
both
inflammatory
neurodegenerative
features.
Although
advances
in
imaging
techniques,
particularly
magnetic
resonance
(MRI),
have
improved
process
diagnosis,
its
cause
unknown,
a
cure
remains
elusive
evidence
base
to
guide
treatment
lacking.
Computational
techniques
like
machine
learning
(ML)
started
be
used
understand
MS.
Published
MS
MRI-based
computational
studies
can
divided
into
five
categories:
automated
diagnosis;
differentiation
between
lesion
types
and/or
stages;
differential
monitoring
predicting
progression;
synthetic
MRI
dataset
generation.
Collectively,
these
approaches
show
promise
assisting
activity
prediction
future
progression,
all
potentially
contributing
management.
Analysis
quality
using
ML
highly
dependent
on
size
variability
for
training.
Wider
public
access
would
mean
larger
datasets
experimentation,
resulting
higher-quality
analysis,
permitting
more
conclusive
research.
This
narrative
review
provides
outline
fundamentals
pathology
pathogenesis,
diagnostic
data
as
well
collating
literature
pertaining
application
towards
developing
better
understanding
IEEE Journal of Biomedical and Health Informatics,
Год журнала:
2022,
Номер
26(6), С. 2680 - 2692
Опубликована: Фев. 16, 2022
Multiple
sclerosis
(MS)
is
a
chronic
inflammatory
and
degenerative
disease
of
the
central
nervous
system,
characterized
by
appearance
focal
lesions
in
white
gray
matter
that
topographically
correlate
with
an
individual
patient's
neurological
symptoms
signs.
Magnetic
resonance
imaging
(MRI)
provides
detailed
in-vivo
structural
information,
permitting
quantification
categorization
MS
critically
inform
management.
Traditionally,
have
been
manually
annotated
on
2D
MRI
slices,
process
inefficient
prone
to
inter-/intra-observer
errors.
Recently,
automated
statistical
analysis
techniques
proposed
detect
segment
based
voxel
intensity.
However,
their
effectiveness
limited
heterogeneity
both
data
acquisition
lesions.
By
learning
complex
lesion
representations
directly
from
images,
deep
achieved
remarkable
breakthroughs
segmentation
task.
Here,
we
provide
comprehensive
review
state-of-the-art
automatic
deep-learning
methods
discuss
current
future
clinical
applications.
Further,
technical
strategies,
such
as
domain
adaptation,
enhance
real-world
settings.
Meta-Radiology,
Год журнала:
2024,
Номер
2(1), С. 100068 - 100068
Опубликована: Фев. 22, 2024
Neurodegenerative
diseases
refer
to
degenerative
of
the
nervous
system
caused
by
neuronal
degeneration
and
apoptosis.
Usually,
onset
disease
is
insidious,
progression
slow,
which
can
last
for
several
years
decades.
Clinical
symptoms
only
appear
in
later
stages
pathological
changes
when
degree
nerve
cell
loss
reaches
or
exceeds
a
certain
threshold.
Traditional
electrophysiological
medical
imaging
techniques
lack
valuable
indicators
markers.
Therefore,
early
diagnosis
differentiation
are
very
difficult.
Radiomics
new
technology
merged
recent
years,
extract
large
number
invisible
features
from
raw
image
data
with
high
throughput,
quantitatively
analyze
physiological
changes.
It
demonstrates
important
potential
value
diagnosis,
grading,
prognosis
evaluation
NDs.
This
review
provides
an
overview
research
progress
radiomics
neurodegenerative
diseases,
emphasizing
process
principles
its
application
classification,
prediction
these
diseases.
helps
deepen
understanding
promote
treatment
clinical
practice.
Frontiers in Neuroscience,
Год журнала:
2023,
Номер
17
Опубликована: Май 18, 2023
Background
and
introduction
Federated
learning
(FL)
has
been
widely
employed
for
medical
image
analysis
to
facilitate
multi-client
collaborative
without
sharing
raw
data.
Despite
great
success,
FL's
applications
remain
suboptimal
in
neuroimage
tasks
such
as
lesion
segmentation
multiple
sclerosis
(MS),
due
variance
characteristics
imparted
by
different
scanners
acquisition
parameters.
Methods
In
this
work,
we
propose
the
first
FL
MS
framework
via
two
effective
re-weighting
mechanisms.
Specifically,
a
learnable
weight
is
assigned
each
local
node
during
aggregation
process,
based
on
its
performance.
addition,
loss
function
client
also
re-weighted
according
volume
data
training.
Results
The
proposed
method
validated
scenarios
using
public
clinical
datasets.
case-wise
voxel-wise
Dice
score
of
under
dataset
65.20
74.30,
respectively.
On
second
in-house
dataset,
53.66,
62.31,
Discussions
conclusions
Comparison
experiments
datasets
have
demonstrated
effectiveness
significantly
outperforming
other
methods.
Furthermore,
performance
incorporating
our
mechanism
can
achieve
comparable
that
from
centralized
training
with
all
American Journal of Neuroradiology,
Год журнала:
2024,
Номер
45(2), С. 236 - 243
Опубликована: Янв. 12, 2024
MS
is
a
chronic
progressive,
idiopathic,
demyelinating
disorder
whose
diagnosis
contingent
on
the
interpretation
of
MR
imaging.
New
imaging
lesions
are
an
early
biomarker
disease
progression.
We
aimed
to
evaluate
machine
learning
model
based
radiomics
features
in
predicting
progression
brain
individuals
with
MS.
Journal of Neurology,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 12, 2024
Multiple
sclerosis
(MS)
is
a
demyelinating
neurological
disorder
with
highly
heterogeneous
clinical
presentation
and
course
of
progression.
Disease-modifying
therapies
are
the
only
available
treatment,
as
there
no
known
cure
for
disease.
Careful
selection
suitable
necessary,
they
can
be
accompanied
by
serious
risks
adverse
effects
such
infection.
Magnetic
resonance
imaging
(MRI)
plays
central
role
in
diagnosis
management
MS,
though
MRI
lesions
have
displayed
moderate
associations
MS
outcomes,
clinico-radiological
paradox.
With
advent
machine
learning
(ML)
healthcare,
predictive
power
improved
leveraging
both
traditional
advanced
ML
algorithms
capable
analyzing
increasingly
complex
patterns
within
neuroimaging
data.
The
purpose
this
review
was
to
examine
application
MRI-based
prediction
disease
Studies
were
divided
into
five
main
categories:
predicting
conversion
clinically
isolated
syndrome
cognitive
outcome,
EDSS-related
disability,
motor
disability
activity.
performance
models
discussed
along
highlighting
influential
MRI-derived
biomarkers.
Overall,
presents
promising
avenue
prognosis.
However,
integration
biomarkers
other
multimodal
patient
data
shows
great
potential
advancing
personalized
healthcare
approaches
MS.
The
majority
of
deep
learning
models
in
medical
image
analysis
concentrate
on
single
snapshot
timepoint
circumstances,
such
as
the
identification
current
pathology
a
given
or
volume.
This
is
often
contrast
to
diagnostic
methodology
radiology
where
presumed
pathologic
findings
are
correlated
prior
studies
and
subsequent
changes
over
time.
For
multiple
sclerosis
(MS),
body
literature
describes
various
forms
lesion
segmentation
with
few
analyzing
disability
progression
purpose
longitudinal
time-dependent
analysis,
we
propose
combinatorial
video
vision
transformer
(ViViT)
benchmarked
against
traditional
recurrent
neural
network
Convolutional
Neural
Network-Long
Short-Term
Memory
(CNN-LSTM)
architectures
hybrid
Vision
Transformer-LSTM
(ViT-LSTM)
predict
long-term
based
upon
Extended
Disability
Severity
Score
(EDSS).
patient
cohort
was
procured
from
two-site
institution
703
patients'
multisequence,
contrast-enhanced
MRIs
cervical
spine
between
years
2002
2023.
Following
competitive
performance
VGG-16-based
CNN-LSTM
compared
ViViT
an
ablation
determine
time-dependency
models.
VGG16-LSTM
predicted
trinary
classification
EDSS
score
6
0.74
AUC
versus
0.84
(p-value
<
0.001
per
5
×
2
cross-validation
F-test)
80:20
hold-out
testing
split.
However,
outperformed
when
patients
only
(n
=
94)
(0.75
0.72
AUC,
respectively).
Exact
investigated
for
both
using
regression
strategies
but
showed
collectively
worse
performance.
Our
experimental
results
demonstrate
ability
MS
stratification
disability,
mimicking
clinical
practice.
Further
work
includes
external
validation
observational
trials.